Selected article for: "antiviral treatment and broad spectrum"
Author: Prasad, Ashish; Prasad, Manoj
Title: Single Virus Targeting Multiple Organs: What We Know and Where We Are Heading?
  • Cord-id: 8f2ygul2
  • Document date: 2020_8_5
    • ID: 8f2ygul2
    Snippet: COVID-19 caused by SARS-CoV-2 has already infected more than 6. 3 million people worldwide as of 1st June 2020 and caused a global medical emergency. Healthcare professionals have been struggling to devise appropriate therapeutic strategies against the virus mainly due to the diverse range of symptoms and multiple-organ failure in infected patients. Several broad-spectrum antiviral drugs are being used for treatment; however, there is yet no specific drug or vaccine against the virus. Multiple-o
    Document: COVID-19 caused by SARS-CoV-2 has already infected more than 6. 3 million people worldwide as of 1st June 2020 and caused a global medical emergency. Healthcare professionals have been struggling to devise appropriate therapeutic strategies against the virus mainly due to the diverse range of symptoms and multiple-organ failure in infected patients. Several broad-spectrum antiviral drugs are being used for treatment; however, there is yet no specific drug or vaccine against the virus. Multiple-organ failure due to hyperactivity of the immune system resulting in cytokine storms is a major reason for death among the 5% critically ill patients. In this article, we have discussed the damage caused by COVID-19 on different organs of the human body.

    Search related documents:
    Co phrase search for related documents
    • liver biopsy and lung damage: 1, 2
    • liver biopsy and lymph node: 1, 2, 3, 4
    • liver damage and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • liver damage and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • liver damage and lymph node: 1, 2
    • liver damage and macrophage monocyte: 1, 2
    • long term usage and lung damage: 1
    • lopinavir ritonavir and lung damage: 1, 2, 3, 4, 5, 6
    • lung damage and lymph node: 1, 2
    • lung damage and macrophage monocyte: 1, 2, 3, 4, 5
    • lymph node and macrophage monocyte: 1, 2